"With their recommendation, the recent inclusion of Oncotype DX in ASCO Guidelines and the majority of U.S. insured lives covered for Oncotype DX, it is clear the clinical community has accepted the test as standard practice for making individualized breast cancer treatment decisions."
Thanks for the information about how insurance claims work with Genomic Healthcare's involvement. I wasn't sure if they would be aggressive in trying to get the insurance company to pay. I have not had any luck myself. I see my cancer doctor on Jan 16th and I am going to bring this to his attention also. Maybe he can write another letter on my behalf.
GHDX will try 3 times with your insurance company before they send you the bill. One of my friend who had the similar reject in the first 2 tries, managed to get the insurance approval on the 3rd. All these tries are done by GHDX -- no patient involvement is required.
I found out I had breast cancer in June of 2007. It was late stage 1. My oncolgist sent some tissue to their lab in California. It took about 2 weeks to get the results back. The test was inconclusive about the chances of the breast cancer coming back. It was in the middle of their scale. I ended up choosing to take Tamoxifen once a day rather than chemo. Their customer service is outstanding to deal with. The only problem I have now is that my health insurance company will not pay for the test. The test costs about $3,600.00
Being too conservative and not in health care, I believe that many have underestimated the importance of the announcements.This will become the standard of care for breast and other cancers.Target prices $18 -$28 ??? An overlooked aspect:Doctors could be sued for NOT utilizing this test ie: if in the future a women dies resulting from chemotherapy complications when chemo should not have been employed.Doctors like hard data to base treatment.Patients want as much information as possible.Lawyers love it!